Search Within

Kylee Maclachlan

Formats
  1. Meeting Abstract (114)
  2. Journal Article (31)
  3. Review (5)
  4. Research Letter (4)
  5. Editorial (2)
  6. Correspondence (1)
Groups
  1. GME, Medicine (157)
  2. Graduate Medical Education (157)
  3. Department of Medicine (137)
  4. Hematologic Malignancies, Division of (133)
  5. Center for Hematologic Malignancies (130)
  6. Myeloma (130)

More Groups

People
  1. Saad Usmani (123)
  2. Alexander Lesokhin (111)
  3. Malin Hultcrantz (103)
  4. Neha Korde (95)
  5. Urvi Shah (94)
  6. Heather Landau (93)

More People

Years
  1. 2025 (6)
  2. 2024 (49)
  3. 2023 (45)
  4. 2022 (31)
  5. 2021 (15)
  6. 2020 (11)
Publications
  1. Blood (70)
  2. Clinical Lymphoma, Myeloma and Leukemia (39)
  3. Blood Cancer Journal (7)
  4. Journal of Clinical Oncology (7)
  5. Blood Advances (6)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. American Society of Hematology (76)
  2. Elsevier Inc. (44)
  3. Nature Publishing Group (13)
  4. American Association for Cancer Research (7)
  5. American Society of Clinical Oncology (7)
  6. Royal College of Pathologists of Australasia (1)

More Publishers

Results (157)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naìˆve multiple myeloma
    Journal Article

    Firestone, R. S.; McAvoy, D.; Shekarkhand, T.; Serrano, E.; Hamadeh, I.; Wang, A.; Zhu, M.; Qin, W. G.; Patel, D.; Tan, C. R.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
    Journal Article

    Costa, B. A.; Flynn, J.; Nishimura, N.; Devlin, S. M.; Farzana, T.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Lahoud, O. B.; Scordo, M.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Genomic classification and individualized prognosis in multiple myeloma
    Journal Article

    Maura, F.; Rajanna, A. R.; Ziccheddu, B.; Poos, A. M.; Derkach, A.; Maclachlan, K.; Durante, M.; Diamond, B.; Papadimitriou, M.; Davies, F.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Impact of rare structural variant events in newly diagnosed multiple myeloma
    Journal Article

    Chojnacka, M.; Diamond, B.; Ziccheddu, B.; Rustad, E.; Maclachlan, K.; Papadimitriou, M.; Boyle, E. M.; Blaney, P.; Usmani, S.; Morgan, G.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups
    Journal Article

    Shah, U. A.; Moshier, E.; Derkach, A.; Huang, Y.; Mailankody, S.; Tan, C. R.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Hassoun, H.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Nivolumab and daratumumab combination regimens for the treatment of relapsed and refractory multiple myeloma: Results of a randomized phase I/II clinical trial
    Journal Article

    Abdallah, A. O.; Lesokhin, A.; Wrobel, T.; Jamroziak, K.; Dytfeld, D.; Touzeau, C.; Suvannasankha, A.; Leleu, X.; Silbermann, R.; Khan, A. M.; more...
    Frontiers in Hematology (2023)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals distinct mutational signatures in multiple myeloma patients with African ancestry compared with those of non-African ancestry
    Meeting Abstract

    Maclachlan, K. H.; Blaney, P.; Cirrincione, A.; Chu, T. R.; Poos, A. M.; Brown, E. E.; Manasanch, E. E.; Hoering, A.; Hou, L. M.; Gagler, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Network modeling of apoptosis-related genes reveal a high-risk cluster in multiple myeloma
    Meeting Abstract

    Simhal, A. K.; Maclachlan, K. H.; Usmani, S. Z.; Norton, L.; Deasy, J. O.; Oh, J. H.; Tannenbaum, A.
    Blood (2023)

    Fulltext@MSK | Save
  • Single cell whole genome measurement of genomic heterogeneity and clonal evolution in multiple myeloma
    Meeting Abstract

    McPherson, A.; Maclachlan, K. H.; Myers, M.; Satas, G.; Landgren, O.; Usmani, S. Z.; Shah, S. P.; Maura, F.
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save